1. Home
  2. SLDB vs ACCO Comparison

SLDB vs ACCO Comparison

Compare SLDB & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • ACCO
  • Stock Information
  • Founded
  • SLDB 2013
  • ACCO 1893
  • Country
  • SLDB United States
  • ACCO United States
  • Employees
  • SLDB N/A
  • ACCO N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • ACCO Publishing
  • Sector
  • SLDB Health Care
  • ACCO Consumer Discretionary
  • Exchange
  • SLDB Nasdaq
  • ACCO Nasdaq
  • Market Cap
  • SLDB 433.0M
  • ACCO 363.2M
  • IPO Year
  • SLDB 2018
  • ACCO N/A
  • Fundamental
  • Price
  • SLDB $5.13
  • ACCO $4.05
  • Analyst Decision
  • SLDB Strong Buy
  • ACCO Buy
  • Analyst Count
  • SLDB 10
  • ACCO 1
  • Target Price
  • SLDB $15.00
  • ACCO $6.00
  • AVG Volume (30 Days)
  • SLDB 872.0K
  • ACCO 502.8K
  • Earning Date
  • SLDB 11-05-2025
  • ACCO 10-30-2025
  • Dividend Yield
  • SLDB N/A
  • ACCO 7.43%
  • EPS Growth
  • SLDB N/A
  • ACCO N/A
  • EPS
  • SLDB N/A
  • ACCO 0.49
  • Revenue
  • SLDB N/A
  • ACCO $1,581,200,000.00
  • Revenue This Year
  • SLDB N/A
  • ACCO N/A
  • Revenue Next Year
  • SLDB N/A
  • ACCO $2.11
  • P/E Ratio
  • SLDB N/A
  • ACCO $8.25
  • Revenue Growth
  • SLDB N/A
  • ACCO N/A
  • 52 Week Low
  • SLDB $2.41
  • ACCO $3.32
  • 52 Week High
  • SLDB $8.45
  • ACCO $6.44
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 36.32
  • ACCO 60.93
  • Support Level
  • SLDB $5.34
  • ACCO $3.90
  • Resistance Level
  • SLDB $5.77
  • ACCO $4.14
  • Average True Range (ATR)
  • SLDB 0.32
  • ACCO 0.09
  • MACD
  • SLDB -0.07
  • ACCO 0.01
  • Stochastic Oscillator
  • SLDB 8.74
  • ACCO 70.31

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

Share on Social Networks: